The median tryptase level in the ISM group increased by 22.6 %; however, the interquartile range of tryptase levels at baseline and best value during the study showed a trend for decreasing tryptase levels.
← all excerpts
Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study.
1
—
—